抗栓丸结合常规疗法治疗缺血性脑中风临床研究

Treatment of ischemic stroke with "Kangshuan Pill" and conventional modality

目的观察抗栓丸结合常规疗法治疗缺血性脑中风的临床疗效。方法将80例患者随机分为治疗组和对照组各40例。两组均采用基础疗法(包括西医常规、电针、康复)治疗,治疗组同时加服抗栓丸;两组均以28天为1个疗程。观察临床疗效及治疗后神经功能缺损积分、生活能力状态分级变化情况。结果治疗组、对照组总有效率分别为97.5%和85.0%;组间疗效比较,差异有统计学意义(P<0.05)。两组治疗第14天、第28天与治疗前比较,神经功能缺损评分、生活能力状态分级差异有统计学意义(P<0.05);治疗组治疗28天与14天比较,神经功能缺损评分、生活能力状态分级差异有统计学意义(P<0.05)。组间治疗后比较,神经功能缺损评分差异有统计学意义(P<0.05)。结论抗栓丸结合常规疗法对缺血性脑中风具有较好的临床疗效,可以明显改善患者神经功能、提高生活能力。

Objective To observe the clinical effects of ＂Kangshuan Pill＂ and conventional modality in the treatment of ischemic stroke.Methods Eighty subjects were divided into two groups：contro1 group in which 40 cases were treated by basic therapy and treatment group in which 40 cases were treated by basic therapy and ＂Kangshuan Pill＂,with a course of 28 days.The clinical efficacy,nerve deficit score and living capacity were assessed.Results The total effective rate was 97.5% in the treatment group and 85.0% in the contro1 group,with a difference between them（P0.05）;after treatment,the nerve deficit score and living capacity were markedly improved in both groups（P0.05）,with a difference between the two groups（P0.05）.Conclusion ＂Kangshuan Pill＂ plus conventional modality is quite effective against ischemic stroke,and in improving neurological function and living capacity.